Fenebrutinib is orally available inhibitor of Brutons tyrosine kinase (BTK) with antineoplastic activity. Upon administration, GDC-0853 inhibits the activity of BTK and prevents the activation of the B-cell antigen receptor (BCR) signaling pathway. This
Molecular Weight:
701.27
CAS Number:
[2128304-54-9]
Formula:
C37H45ClN8O4
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted